MFN2 and metabolic dysfunction-associated steatotic liver disease: Intriguingly, a recent study disclosed MFN2 as a key factor in the development of non-alcoholic fatty liver disease (NAFLD) and liver cancer, due to its role in transferring PS at the EMCS.